-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M/cMljGb8AyqNL9dtd+0l3nRwDrHOzMNydFlSRPMlRX+hNP0FxhIrKpN4TuBXx4E peDYcfaAygMaOf9WHSTpXA== 0001209191-07-007225.txt : 20070202 0001209191-07-007225.hdr.sgml : 20070202 20070202164746 ACCESSION NUMBER: 0001209191-07-007225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070126 FILED AS OF DATE: 20070202 DATE AS OF CHANGE: 20070202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ILLUMINA INC CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 07577118 BUSINESS ADDRESS: STREET 1: 9885 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 9885 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 bny29885_ii4.xml MAIN DOCUMENT DESCRIPTION X0202 4 2007-01-26 1 0000913275 Solexa, Inc. SLXA 0001110803 ILLUMINA INC 9885 TOWNE CENTRE DRIVE SAN DIEGO CA 92121-1975 0 0 1 0 Common Stock, par value $0.01 per share 2007-01-26 4 J 0 38122885 A 43277524 D Securities acquired in a business combinaton transaction pursuant to which Solexa, Inc. became a direct, wholly owned subsidiary of Illumina, Inc. Each outstanding share of common stock of Solexa, Inc. was converted into 0.344 of a share of common stock of Illumina, Inc. /s/ Christian O. Henry, Senior Vice President and CFO 2007-02-02 -----END PRIVACY-ENHANCED MESSAGE-----